Earnings Feed
Start Free
LEMAITRE VASCULAR INC·4

Mar 30, 5:57 PM ET

Roberts David B 4

4 · LEMAITRE VASCULAR INC · Filed Mar 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Lemaitre Vascular (LMAT) President David Roberts Receives Award

What Happened

  • David B. Roberts, President and Director of Lemaitre Vascular (LMAT), was credited with nine dividend-equivalent rights on 2026-03-26 totaling 18.084 shares. Each item was reported as an award/other acquisition (code A) at $0.00 per share (derivative instrument), so no cash changed hands on the Form 4.
  • These dividend-equivalent rights are the economic equivalent of common shares and vest proportionately with previously granted restricted stock units (RSUs) and performance share units (PSUs). The awards were not open-market purchases or sales and thus are administrative/compensation-related, not immediate signals of buying or selling.

Key Details

  • Transaction date: 2026-03-26; Filing date: 2026-03-30 (filed within the 2-business-day Form 4 deadline).
  • Amount credited: nine entries totaling 18.084 dividend-equivalent rights; price reported $0.00 (derivative award).
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Footnotes: each line represents dividend equivalents that accrued on earlier awards and vest with those awards — F1/F2: awards from 12/12/2022; F3/F4: 12/08/2023; F5/F6: 12/06/2024; F7/F8: 02/18/2025; F9: 12/10/2025. Each dividend equivalent equals one share of common stock.
  • No 10b5-1 plan, sale, gift, or tax-withholding action is indicated in this transaction.

Context

  • Dividend-equivalent rights are typically administrative credits that mirror dividends on outstanding RSUs/PSUs and vest according to the original award terms; they do not represent a market purchase or sale. They generally reflect compensation mechanics rather than a direct insider signal to buy or sell stock.

Insider Transaction Report

Form 4
Period: 2026-03-26
LEMAITRE VASCULAR INCLMAT
Roberts David B
DirectorPresident and Director
Transactions
  • Award

    Dividend Equivalent Rights

    [F1]
    2026-03-26+1.544→ 21.518 total
    → Common Stock (1.544 underlying)
  • Award

    Dividend Equivalent Rights

    [F2]
    2026-03-26+1.544→ 20.835 total
    → Common Stock (1.544 underlying)
  • Award

    Dividend Equivalent Rights

    [F3]
    2026-03-26+2.637→ 23.591 total
    → Common Stock (2.637 underlying)
  • Award

    Dividend Equivalent Rights

    [F4]
    2026-03-26+3.16→ 24.295 total
    → Common Stock (3.16 underlying)
  • Award

    Dividend Equivalent Rights

    [F5]
    2026-03-26+2.291→ 11.675 total
    → Common Stock (2.291 underlying)
  • Award

    Dividend Equivalent Rights

    [F6]
    2026-03-26+2.596→ 11.98 total
    → Common Stock (2.596 underlying)
  • Award

    Dividend Equivalent Rights

    [F7]
    2026-03-26+0.222→ 1.418 total
    → Common Stock (0.222 underlying)
  • Award

    Dividend Equivalent Rights

    [F8]
    2026-03-26+0.251→ 1.448 total
    → Common Stock (0.251 underlying)
  • Award

    Dividend Equivalent Rights

    [F9]
    2026-03-26+3.839→ 3.839 total
    → Common Stock (3.839 underlying)
Footnotes (9)
  • [F1]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F2]These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F3]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F4]These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F5]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F6]These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F7]These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F8]These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F9]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-03-30

Documents

1 file
  • 4
    ownership.xmlPrimary

    4